PD CEN/TS 17981-2:2023 In vitro diagnostic Next Generation Sequencing (NGS) workflows Human RNA examination

Standard number: PD CEN/TS 17981-2:2023

Pages: 68

Released: 2023-12-04

ISBN: 978 0 539 21304 1

Status: Standard

Unlock the Future of Diagnostic Excellence with PD CEN/TS 17981-2:2023

Welcome to the cutting-edge world of Next Generation Sequencing (NGS) with the latest standard, PD CEN/TS 17981-2:2023. This comprehensive document is your ultimate guide to mastering in vitro diagnostic workflows for Human RNA examination. Whether you are a seasoned professional or a newcomer to the field, this standard is designed to elevate your expertise and ensure the highest quality in your diagnostic processes.

Why Choose PD CEN/TS 17981-2:2023?

In the rapidly evolving field of molecular diagnostics, staying ahead of the curve is crucial. The PD CEN/TS 17981-2:2023 standard provides you with the most up-to-date methodologies and best practices for NGS workflows. Here’s why this standard is indispensable:

• Comprehensive Coverage: Spanning 68 pages, this standard offers an in-depth exploration of NGS workflows, ensuring you have all the information you need at your fingertips.
• Latest Release: Published on 2023-12-04, this standard reflects the most current advancements and innovations in the field.
• Expertly Crafted: Developed by leading experts, this standard is a testament to the highest level of scientific and technical rigor.
• ISBN: 978 0 539 21304 1 – Easily reference and cite this authoritative source in your research and professional work.

Key Features and Benefits

The PD CEN/TS 17981-2:2023 standard is packed with features that make it an essential tool for any laboratory or research facility:

• Detailed Protocols: Step-by-step instructions for NGS workflows, ensuring precision and reproducibility in your experiments.
• Quality Assurance: Guidelines for maintaining the highest standards of quality control and assurance in your diagnostic processes.
• Human RNA Examination: Specialized focus on human RNA, providing targeted insights and methodologies for this critical area of research.
• Innovative Techniques: Incorporates the latest technological advancements and innovative techniques in NGS.
• Regulatory Compliance: Ensures your workflows are compliant with the latest regulatory standards and guidelines.

Who Should Use This Standard?

The PD CEN/TS 17981-2:2023 standard is designed for a wide range of professionals in the field of molecular diagnostics, including:

• Clinical Laboratory Scientists: Enhance your diagnostic capabilities with the latest NGS methodologies.
• Research Scientists: Stay at the forefront of RNA research with cutting-edge techniques and protocols.
• Quality Assurance Professionals: Ensure your laboratory meets the highest standards of quality and compliance.
• Regulatory Affairs Specialists: Navigate the complex landscape of regulatory requirements with confidence.
• Educators and Trainers: Equip your students and trainees with the most current and comprehensive knowledge in NGS workflows.

Invest in Excellence

By adopting the PD CEN/TS 17981-2:2023 standard, you are investing in the future of diagnostic excellence. This standard not only enhances your technical capabilities but also positions your laboratory or research facility as a leader in the field of molecular diagnostics.

Stay Ahead with the Latest Innovations

The field of molecular diagnostics is constantly evolving, and staying updated with the latest standards is crucial for maintaining a competitive edge. The PD CEN/TS 17981-2:2023 standard is your gateway to the latest innovations and best practices in NGS workflows. With this standard, you can be confident that you are utilizing the most advanced and effective methodologies available.

Conclusion

In summary, the PD CEN/TS 17981-2:2023 standard is an invaluable resource for anyone involved in the field of molecular diagnostics. Its comprehensive coverage, expert insights, and focus on quality assurance make it an essential tool for achieving excellence in NGS workflows for human RNA examination. Don’t miss out on the opportunity to elevate your diagnostic capabilities and stay ahead in this rapidly advancing field.

Order your copy of the PD CEN/TS 17981-2:2023 standard today and take the first step towards mastering the future of molecular diagnostics.

PD CEN/TS 17981-2:2023

This standard PD CEN/TS 17981-2:2023 In vitro diagnostic Next Generation Sequencing (NGS) workflows is classified in these ICS categories:

• 11.100.10 In vitro diagnostic test systems

This document specifies requirements and gives recommendations for next generation sequencing (NGS) workflows for in vitro diagnostics and biomedical research. This document covers the pre-examination processes, human RNA isolation, sequencing library preparation, sequencing, sequence analysis and reporting of the examination of sequences for diagnostic purposes from isolated RNA from, e.g. formalin-fixed and paraffin embedded tissues, fresh frozen tissues, fine needle aspirates (FNA), whole blood, circulating tumour cells (CTCs), exosomes and other extracellular vesicles, and circulating cell free RNA from plasma. NOTE 1 Typical applications include, but are not limited to, NGS for oncology and clinical genetics, certain single-cell analyses. This document is applicable to molecular in vitro diagnostic examinations including laboratory developed tests performed by medical laboratories, molecular pathology laboratories and molecular genetic laboratories. This document is also applicable to laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions, and organisations performing biomedical research. This document is not applicable for in situ sequencing, forensic sequencing, sequencing of pathogens or microorganisms and microbiome analysis. NOTE 2 International, national or regional regulations or requirements or multiples of them can also apply to specific topics covered in this document.